Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Avisa Diagnostics Inc FOGCF

Avisa Diagnostics Inc. is a clinical-stage medical device company. The Company is engaged in the development of the Allora BreathTest (ABT), a drug/device biomarker technology platform. The Allora BreathTest (ABT) is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load. ABT enables the ultra-rapid detection of virulent bacterial pathogens... see more

GREY:FOGCF - Post Discussion

Avisa Diagnostics Inc > Anything new?
View:
Post by Millhouse501 on Mar 05, 2021 8:05pm

Anything new?

Any news at all or we just sitting here in limbo for a while longer?
Comment by Diomio on Mar 06, 2021 7:42am
News coming end of month once it is ready to list as new symbol... they are not allowed to post news before that. ...thats what I was told.
Comment by frewil11 on Apr 02, 2021 8:07pm
We should be hearing something soon , this was expected to close buy the end of first quarter 2021. [ March 31 ]
Comment by Diomio on Apr 06, 2021 8:06am
They have been approved to list on the cse.... in a week or so. New company name and ticker! News will be released once listed. Glta
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities